Cargando…
Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study
Patients with schizophrenia spectrum disorders have a reduced life expectancy, which is largely the consequence of a high co-occurrence of cardiovascular diseases. To date, several intrinsic and environmental factors underlying this phenomenon have been found. However, the association with psychosoc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760156/ https://www.ncbi.nlm.nih.gov/pubmed/33255883 http://dx.doi.org/10.3390/jcm9123822 |
_version_ | 1783627266613313536 |
---|---|
author | Misiak, Błażej Piotrowski, Patryk Beszłej, Jan Aleksander Kalinowska, Sylwia Chęć, Magdalena Samochowiec, Jerzy |
author_facet | Misiak, Błażej Piotrowski, Patryk Beszłej, Jan Aleksander Kalinowska, Sylwia Chęć, Magdalena Samochowiec, Jerzy |
author_sort | Misiak, Błażej |
collection | PubMed |
description | Patients with schizophrenia spectrum disorders have a reduced life expectancy, which is largely the consequence of a high co-occurrence of cardiovascular diseases. To date, several intrinsic and environmental factors underlying this phenomenon have been found. However, the association with psychosocial stress has not been extensively addressed. In this study, we tested the relationship between a history of adverse childhood experiences (ACEs), lifetime stressors, perceived stress and metabolic parameters in patients with schizophrenia spectrum disorders and in healthy controls. The participants included 85 inpatients with schizophrenia spectrum disorders and 56 healthy controls. Serum levels of glucose, insulin, low- and high-density lipoproteins (LDL and HDL), triglycerides, total cholesterol and high-sensitivity C-reactive protein (hsCRP) were determined. After adjustment for potential confounding factors, patients had significantly higher levels of glucose (F = 4.856, p = 0.030), triglycerides (F = 4.720, p = 0.032) and hsCRP (F = 7.499, p = 0.007) as well as significantly lower levels of HDL (F = 5.300, p = 0.023) compared to healthy controls. There were also significant effects of interactions between diagnosis and a history of ACEs on the levels of insulin (F = 4.497, p = 0.036) and homeostatic model assessment of insulin resistance (HOMA-IR) (F = 3.987, p = 0.048). More specifically, the levels of insulin and HOMA-IR were significantly higher in the subgroup of patients with schizophrenia spectrum disorders and a positive history of ACEs compared to other subgroups of participants. No significant associations between lifetime stressors and perceived stress with metabolic parameters were found. Our findings indicate that a history of ACEs might be associated with insulin resistance in patients with schizophrenia spectrum disorders. Therapeutic strategies targeting early-life stress should be considered with early interventions that aim to manage cardiometabolic comorbidity in patients with schizophrenia spectrum disorders. |
format | Online Article Text |
id | pubmed-7760156 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77601562020-12-26 Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study Misiak, Błażej Piotrowski, Patryk Beszłej, Jan Aleksander Kalinowska, Sylwia Chęć, Magdalena Samochowiec, Jerzy J Clin Med Article Patients with schizophrenia spectrum disorders have a reduced life expectancy, which is largely the consequence of a high co-occurrence of cardiovascular diseases. To date, several intrinsic and environmental factors underlying this phenomenon have been found. However, the association with psychosocial stress has not been extensively addressed. In this study, we tested the relationship between a history of adverse childhood experiences (ACEs), lifetime stressors, perceived stress and metabolic parameters in patients with schizophrenia spectrum disorders and in healthy controls. The participants included 85 inpatients with schizophrenia spectrum disorders and 56 healthy controls. Serum levels of glucose, insulin, low- and high-density lipoproteins (LDL and HDL), triglycerides, total cholesterol and high-sensitivity C-reactive protein (hsCRP) were determined. After adjustment for potential confounding factors, patients had significantly higher levels of glucose (F = 4.856, p = 0.030), triglycerides (F = 4.720, p = 0.032) and hsCRP (F = 7.499, p = 0.007) as well as significantly lower levels of HDL (F = 5.300, p = 0.023) compared to healthy controls. There were also significant effects of interactions between diagnosis and a history of ACEs on the levels of insulin (F = 4.497, p = 0.036) and homeostatic model assessment of insulin resistance (HOMA-IR) (F = 3.987, p = 0.048). More specifically, the levels of insulin and HOMA-IR were significantly higher in the subgroup of patients with schizophrenia spectrum disorders and a positive history of ACEs compared to other subgroups of participants. No significant associations between lifetime stressors and perceived stress with metabolic parameters were found. Our findings indicate that a history of ACEs might be associated with insulin resistance in patients with schizophrenia spectrum disorders. Therapeutic strategies targeting early-life stress should be considered with early interventions that aim to manage cardiometabolic comorbidity in patients with schizophrenia spectrum disorders. MDPI 2020-11-26 /pmc/articles/PMC7760156/ /pubmed/33255883 http://dx.doi.org/10.3390/jcm9123822 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Misiak, Błażej Piotrowski, Patryk Beszłej, Jan Aleksander Kalinowska, Sylwia Chęć, Magdalena Samochowiec, Jerzy Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study |
title | Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study |
title_full | Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study |
title_fullStr | Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study |
title_full_unstemmed | Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study |
title_short | Metabolic Dysregulation and Psychosocial Stress in Patients with Schizophrenia Spectrum Disorders: A Case-Control Study |
title_sort | metabolic dysregulation and psychosocial stress in patients with schizophrenia spectrum disorders: a case-control study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760156/ https://www.ncbi.nlm.nih.gov/pubmed/33255883 http://dx.doi.org/10.3390/jcm9123822 |
work_keys_str_mv | AT misiakbłazej metabolicdysregulationandpsychosocialstressinpatientswithschizophreniaspectrumdisordersacasecontrolstudy AT piotrowskipatryk metabolicdysregulationandpsychosocialstressinpatientswithschizophreniaspectrumdisordersacasecontrolstudy AT beszłejjanaleksander metabolicdysregulationandpsychosocialstressinpatientswithschizophreniaspectrumdisordersacasecontrolstudy AT kalinowskasylwia metabolicdysregulationandpsychosocialstressinpatientswithschizophreniaspectrumdisordersacasecontrolstudy AT checmagdalena metabolicdysregulationandpsychosocialstressinpatientswithschizophreniaspectrumdisordersacasecontrolstudy AT samochowiecjerzy metabolicdysregulationandpsychosocialstressinpatientswithschizophreniaspectrumdisordersacasecontrolstudy |